Auteurs Habel N, El-Hachem N, Soysouvanh F, Hadhiri-Bzioueche H, Giuliano S, Nguyen S, Horák P, Gay AS, Debayle D, Nottet N, Béranger G, Paillerets BB, Bertolotto C, Ballotti R
Cell death and differentiation Jan 2021
Discovery of a new molecule inducing melanoma cell death: dual AMPK/MELK targeting for novel melanoma therapies.Auteurs Jaune E, Cavazza E, Ronco C, Grytsai O, Abbe P, Tekaya N, Zerhouni M, Beranger G, Kaminski L, Bost F, Gesson M, Tulic M, Hofman P, Ballotti R, Passeron T, Botton T, Benhida R, Rocchi S
Cell death & disease Jan 2021
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity.Auteurs Cheli Y, Tulic MK, El Hachem N, Nottet N, Jacquel A, Gesson M, Strub T, Bille K, Picard-Gauci A, Montaudié H, Beranger GE, Passeron T, Close P, Bertolotto C, Ballotti R
Molecular cancer Jan 2021
Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy.Auteurs Cerezo M, Rocchi S
Cell death & disease Nov 2020
Sulfonylguanidine Derivatives as Potential Antimelanoma Agents.Auteurs Baladi T, Hamouda-Tekaya N, Gonçalves LCP, Rocchi S, Ronco C, Benhida R
ChemMedChem Mai 2020
A role for early oral exposure to house dust mite allergens through breast milk in IgE-mediated food allergy susceptibility.Auteurs Rekima A, Bonnart C, Macchiaverni P, Metcalfe J, Tulic MK, Halloin N, Rekima S, Genuneit J, Zanelli S, Medeiros S, Palmer DJ, Prescott S, Verhasselt V
The Journal of allergy and clinical immunology Jan 2020
Ovalbumin in breastmilk is associated with a decreased risk of IgE-mediated egg allergy in children.Auteurs Verhasselt V, Genuneit J, Metcalfe JR, Tulic MK, Rekima A, Palmer DJ, Prescott SL
Allergy Jan 2020
Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia.Auteurs Cluzeau T, Furstoss N, Savy C, El Manaa W, Zerhouni M, Blot L, Calleja A, Dufies M, Dubois A, Ginet C, Mounier N, Garnier G, Raynaud S, Rohrlich PS, Peterlin P, Stamatoullas A, Chermat F, Fenaux P, Jacquel A, Robert G, Auberger P
International journal of molecular sciences Dec 2019
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.Auteurs Botton T, Talevich E, Mishra VK, Zhang T, Shain AH, Berquet C, Gagnon A, Judson RL, Ballotti R, Ribas A, Herlyn M, Rocchi S, Brown KM, Hayward NK, Yeh I, Bastian BC
Cell reports Oct 2019
Genetic Heterogeneity of BRAF Fusion Kinases in Melanoma Affects Drug Responses.Auteurs Botton T, Talevich E, Mishra VK, Zhang T, Shain AH, Berquet C, Gagnon A, Judson RL, Ballotti R, Ribas A, Herlyn M, Rocchi S, Brown KM, Hayward NK, Yeh I, Bastian BC
Cell reports Oct 2019